Showing 1 posts of 1 posts found.
The last five years have seen a shift in pharmacoeconomics to the centre of corporate concerns. Pharmacoeconomics used to be …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO